Published in Am J Psychiatry on February 01, 1995
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A (1996) 2.22
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr Bull (2008) 1.61
Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev (2010) 1.38
Preattentive sensory processing as indexed by the MMN and P3a brain responses is associated with cognitive and psychosocial functioning in healthy adults. J Cogn Neurosci (2007) 1.28
Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics (2008) 1.17
Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry (2010) 1.16
Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull (2009) 1.14
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl) (2008) 1.09
Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol Psychiatry (2013) 1.04
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res (2014) 1.00
Mismatch negativity: translating the potential. Front Psychiatry (2013) 0.97
Epidural Auditory Event-Related Potentials in the Rat to Frequency and duration Deviants: Evidence of Mismatch Negativity? Front Psychol (2011) 0.97
Auditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset. BMC Psychiatry (2006) 0.89
Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology (Berl) (2009) 0.89
Mismatch negativity (MMN) as an index of cognitive dysfunction. Brain Topogr (2014) 0.89
Mismatch negativity at acute and post-acute phases of first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2008) 0.89
Electroencephalography (EEG) and event-related potentials (ERPs) with human participants. Curr Protoc Neurosci (2010) 0.89
The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study. Psychopharmacology (Berl) (2008) 0.88
Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann N Y Acad Sci (2015) 0.87
Biomarkers for the effects of antipsychotic drugs in healthy volunteers. Br J Clin Pharmacol (2001) 0.87
Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests. PLoS One (2012) 0.87
Biomarkers of bipolar disorder: specific or shared with schizophrenia? Front Biosci (Elite Ed) (2013) 0.86
Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder. Schizophr Bull (2008) 0.86
Somatosensory system deficits in schizophrenia revealed by MEG during a median-nerve oddball task. Brain Topogr (2009) 0.86
Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses. Biomark Med (2014) 0.86
Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Curr Pharm Des (2014) 0.86
Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia. Bipolar Disord (2012) 0.85
Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia. Neuroimage Clin (2014) 0.85
Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge. J Psychiatry Neurosci (2001) 0.84
Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster. J Psychiatry Neurosci (2012) 0.84
Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis. BMC Psychiatry (2013) 0.84
Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. Neuropsychopharmacology (2015) 0.84
Mismatch negativity latency and cognitive function in schizophrenia. PLoS One (2014) 0.81
Altered visual information processing systems in bipolar disorder: evidence from visual MMN and P3. Front Hum Neurosci (2013) 0.81
Explicit Time Deficit in Schizophrenia: Systematic Review and Meta-Analysis Indicate It Is Primary and Not Domain Specific. Schizophr Bull (2015) 0.81
Mismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis. PLoS One (2014) 0.80
Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls. Psychopharmacology (Berl) (2007) 0.80
Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biol Psychol (2015) 0.79
Mismatch negativity, social cognition, and functional outcomes in patients after traumatic brain injury. Neural Regen Res (2015) 0.76
Electrophysiological Endophenotypes for Schizophrenia. Harv Rev Psychiatry (2016) 0.76
Detecting Temporal Change in Dynamic Sounds: On the Role of Stimulus Duration, Speed, and Emotion. Front Psychol (2016) 0.75
Mismatch Negativity to Threatening Voices Associated with Positive Symptoms in Schizophrenia. Front Hum Neurosci (2016) 0.75
Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder. Neuropsychiatr Dis Treat (2016) 0.75
No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach. Schizophr Res Cogn (2017) 0.75
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Complete nucleotide sequence of Saccharomyces cerevisiae chromosome VIII. Science (1994) 3.97
Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position. BJU Int (2001) 2.01
The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS (2005) 1.72
The reliability of digital images when used to assess burn wounds. J Telemed Telecare (2003) 1.54
Decrement of the N1 auditory event-related potential with stimulus repetition: habituation vs. refractoriness. Int J Psychophysiol (1998) 1.54
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry (1991) 1.48
From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs. Respir Med (2000) 1.44
Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. Psychiatry Res (1996) 1.43
Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry (2000) 1.41
Perineal trauma from cassette tape boxes. Br J Surg (1992) 1.39
Disturbed communication in schizophrenia: the role of poor pragmatics and poor mind-reading. Psychol Med (2002) 1.28
Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry (1995) 1.27
Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalogr Clin Neurophysiol (1998) 1.27
Acts of control in schizophrenia: dissociating the components of inhibition. Psychol Med (2002) 1.26
Impulsivity in pathological gambling: the antisocial impulsivist. Addiction (1997) 1.22
Patterns of psychiatric morbidity in a genito-urinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry (1988) 1.20
Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology (1985) 1.18
Boredom proneness in pathological gambling. Psychol Rep (1990) 1.16
Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis (2001) 1.16
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull (2009) 1.14
Early selective-attention effects on the evoked potential: a critical review and reinterpretation. Biol Psychol (1979) 1.14
Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophr Bull (1999) 1.10
Acquired venous aneurysms. Br J Sports Med (1991) 1.07
Profiling bacterial survival through a water treatment process and subsequent distribution system. J Appl Microbiol (2005) 1.07
Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology (1991) 1.07
PCR amplification from fixed tissue indicates frequent involvement of Brachyspira aalborgi in human intestinal spirochetosis. J Clin Microbiol (1999) 1.07
Role of the indigenous medicine practitioner in two areas of India. Report of a study. Soc Sci Med (1971) 1.05
Superior temporal gyral volumes and laterality correlates of auditory hallucinations in schizophrenia. Biol Psychiatry (1999) 1.02
The anaerobic oxidation of dihydroorotate by Escherichia coli K-12. Biochim Biophys Acta (1977) 1.00
Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission. Aust N Z J Psychiatry (2000) 1.00
Improved detection of vanB2-containing enterococcus faecium with vancomycin susceptibility by Etest using oxgall supplementation. J Clin Microbiol (2008) 0.99
The effects of spatial selective attention on the somatosensory event-related potential. Psychophysiology (1987) 0.98
Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia. Clin Neurophysiol (2003) 0.97
Pathological gamblers, heroin addicts and controls compared on the E.P.Q. 'Addiction Scale'. Br J Addict (1985) 0.97
The spatial and temporal dynamics of anticipatory preparation and response inhibition in task-switching. Neuroimage (2010) 0.97
A controlled trial of imipramine, amphetamine, pad-and-bell conditioning and random awakening in the treatment of nocturnal enuresis. Med J Aust (1969) 0.97
Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol (2004) 0.96
Effects of long-term cannabis use on selective attention: an event-related potential study. Pharmacol Biochem Behav (1991) 0.95
Active and passive attention in schizophrenia: an ERP study of information processing in a linguistic task. Biol Psychol (1992) 0.93
Subjective and penile plethysmograph responses following aversion-relief and apomorphine aversion therapy for homosexual impulses. Br J Psychiatry (1969) 0.93
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance. Oncogene (2012) 0.93
Sensation seeking and pathological gambling. Br J Addict (1986) 0.93
Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling. Br J Psychiatry (1983) 0.92
Late-onset depression: genetic, vascular and clinical contributions. Psychol Med (2001) 0.91
Facilitation of the N1 peak of the auditory ERP at short stimulus intervals. Neuroreport (1994) 0.91
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma. Cancer Chemother Pharmacol (2010) 0.91
Emergence of novel Leptospira serovars: a need for adjusting vaccination policies for dogs? Epidemiol Infect (2012) 0.89
Event-related potential indices of semantic processing in schizophrenia. Biol Psychiatry (1993) 0.89
Impaired categorical perception of synthetic speech sounds in schizophrenia. Biol Psychiatry (1999) 0.89
Effects of inter-item lag on word repetition: an event-related potential study. Psychophysiology (1991) 0.89
Familial relationships of allusive thinking in university students and their parents. Br J Psychiatry (1968) 0.89
ERP correlates of response inhibition to elemental and configural stimuli in a negative patterning task. Clin Neurophysiol (2000) 0.89
Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol (2001) 0.88
Defective Self and/or Other Mentalising in Schizophrenia: A Cognitive Neuropsychological Approach. Cogn Neuropsychiatry (1997) 0.86
Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection. J Antimicrob Chemother (2010) 0.86
The independence of neurotic and endogenous depression. Br J Psychiatry (1967) 0.86
Penile volume change to moving pictures of male and female nudes in heterosexual and homosexual males. Behav Res Ther (1967) 0.85
Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment. Transl Psychiatry (2013) 0.85
Bacteriophages associated with multiresistant Staphylococcus aureus in Australia. J Med Microbiol (1987) 0.85
Campylobacter upsaliensis gastroenteritis in childhood. Pediatr Infect Dis J (1999) 0.85
Brachyspira aalborgi infection in four Australian children. J Gastroenterol Hepatol (2001) 0.85
Purification and properties of 3-deoxy-d-arabinoheptulosonic acid-7-phosphate synthetase (phe) from a lambda aroG+ transductant of Escherichia coli. J Bacteriol (1971) 0.84
Frontal processing negativity in a visual selective attention task. Electroencephalogr Clin Neurophysiol (1996) 0.84
Selective attention effects on somatosensory event-related potentials. Ann N Y Acad Sci (1984) 0.84
High prevalence of gynecologic disease among hospitalized women with human immunodeficiency virus infection. Clin Infect Dis (1997) 0.84
Auditory selective attention and event-related potentials in schizophrenia. Br J Psychiatry (1991) 0.84
Hazards of domiciliary oxygen therapy. Respir Med (1993) 0.84
The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse. Soc Psychiatry Psychiatr Epidemiol (1992) 0.84
Genetically distinct strains of Candida albicans with elevated secretory proteinase production are associated with diarrhoea in hospitalized children. J Gastroenterol Hepatol (2000) 0.83
Creativity, divergent and allusive thinking in students and visual artists. Psychol Med (1982) 0.83
Selective medium for isolation of Fusarium species and dematiaceous hyphomycetes from cereals. Appl Environ Microbiol (1986) 0.83
The effect of repeated testing on ERP components during auditory selective attention. Psychophysiology (1991) 0.83
The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int J Cancer (2001) 0.83
An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. Br J Pharmacol (1995) 0.83
Evidence of visual processing negativity with attention to orientation and color in central space. Electroencephalogr Clin Neurophysiol (1997) 0.82
Auditory sensory memory in schizophrenia: inadequate trace formation? Psychiatry Res (2000) 0.82
An event-related potential study of semantic congruity and repetition in a sentence-reading task: effects of context change. Psychophysiology (1993) 0.82
Criminal offenses in gamblers anonymous and hospital treated pathological gamblers. J Gambl Stud (1994) 0.82